title: 4-methylcoumarin derivatives inhibit human neutrophil oxidative metabolism and elastase activity.
abstract: Increased neutrophil activation significantly contributes to the tissue damage in inflammatory illnesses; this phenomenon has motivated the search for new compounds to modulate their effector functions. Coumarins are natural products that are widely consumed in the human diet. We have evaluated the antioxidant and immunomodulator potential of five 4-methylcoumarin derivatives. We found that the 4-methylcoumarin derivatives inhibited the generation of reactive oxygen species by human neutrophils triggered by serum-opsonized zymosan or phorbol-12-myristate-13-acetate; this inhibition occurred in a concentration-dependent manner, as revealed by lucigenin- and luminol-enhanced chemiluminescence assays. Cytotoxicity did not mediate this inhibitory effect. The 7,8-dihydroxy-4-methylcoumarin suppressed the neutrophil oxidative metabolism more effectively than the 6,7- and 5,7-dihydroxy-4-methylcoumarins, but the 5,7- and 7,8-diacetoxy-4-methylcoumarins were less effective than their hydroxylated counterparts. An analysis of the biochemical pathways suggested that the 6,7- and 7,8-dihydroxy-4-methylcoumarins inhibit the protein kinase C-mediated signaling pathway, but 5,7-dihydroxy-4-methylcoumarin, as well as 5,7- and 7,8-diacetoxy-4-methylcoumarins do not significantly interfere in this pathway of the activation of the human neutrophil oxidative metabolism. The 4-methylcoumarin derivatives bearing the catechol group suppressed the elastase and myeloperoxidase activity and reduced the 1,1-diphenyl-2-picrylhydrazyl free radical the most strongly. Interestingly, the 5,7-dihydroxy-4-methylcoumarin scavenged hypochlorous acid more effectively than the o-dihydroxy-substituted 4-methylcoumarin derivatives, and the diacetoxylated 4-methylcoumarin derivatives scavenged hypochlorous acid as effectively as the 7,8-dihydroxy-4-methylcoumarin. The significant influence of small structural modifications in the inhibitory potential of 4-methylcoumarin derivatives on the effector functions of neutrophil makes them interesting candidates to develop new drugs for the treatment of inflammatory diseases mediated by increased neutrophil activation.
authors.affiliation: Department of Physics and Chemistry, School of Pharmaceutical Sciences, University of São Paulo, Ribeirão Preto, São Paulo, Brazil. luciana_kabeya@yahoo.com.br
authors.forename: Luciana M
authors.initials: LM
authors.lastname: Kabeya
authors.forename: Carolina N
authors.initials: CN
authors.lastname: Fuzissaki
authors.forename: Micássio F
authors.initials: MF
authors.lastname: Andrade
authors.forename: Ana Elisa C S
authors.initials: AE
authors.lastname: Azzolini
authors.forename: Silvia H
authors.initials: SH
authors.lastname: Taleb-Contini
authors.forename: Roberta B
authors.initials: RB
authors.lastname: Vermelho
authors.forename: João Luis C
authors.initials: JL
authors.lastname: Lopes
authors.forename: Yara Maria
authors.initials: YM
authors.lastname: Lucisano-Valim
mesh_terms: D000328:Adult; D000975:Antioxidants / Q000737:chemistry / Q000494:pharmacology; D002478:Cells, Cultured; D003374:Coumarins / Q000737:chemistry / Q000494:pharmacology*; D015536:Down-Regulation / Q000187:drug effects*; D006801:Humans; D009504:Neutrophils / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism*; D010196:Pancreatic Elastase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D017382:Reactive Oxygen Species / Q000378:metabolism
chemical_list: D000975:Antioxidants; D003374:Coumarins; D017382:Reactive Oxygen Species; D010196:Pancreatic Elastase
references.citation: Free Radic Biol Med. 2010 Dec 15;49(12):1834-45
references.pmid: 20870019
references.citation: J Pharm Pharmacol. 2007 Dec;59(12):1721-8
references.pmid: 18053335
references.citation: Am J Clin Nutr. 2004 Jul;80(1):15-21
references.pmid: 15213022
references.citation: Am J Clin Nutr. 2005 Jan;81(1 Suppl):230S-242S
references.pmid: 15640486
references.citation: Methods. 1996 Jun;9(3):591-606
references.pmid: 8812714
references.citation: Phytother Res. 2004 Jan;18(1):61-5
references.pmid: 14750203
references.citation: Chem Biol Interact. 2012 Jan 5;195(1):76-85
references.pmid: 22119283
references.citation: Z Naturforsch C J Biosci. 2007 May-Jun;62(5-6):339-47
references.pmid: 17708437
references.citation: Z Naturforsch C J Biosci. 2007 May-Jun;62(5-6):357-61
references.pmid: 17708440
references.citation: Bioorg Med Chem. 2005 Mar 1;13(5):1605-13
references.pmid: 15698778
references.citation: Res Commun Mol Pathol Pharmacol. 2002;111(1-4):103-13
references.pmid: 14632318
references.citation: J Pharmacol Toxicol Methods. 2002 Jan-Feb;47(1):53-8
references.pmid: 12387939
references.citation: Food Chem Toxicol. 1999 Apr;37(4):423-53
references.pmid: 10418958
references.citation: Life Sci. 2007 Jul 4;81(4):317-26
references.pmid: 17610907
references.citation: Biol Pharm Bull. 2003 Jun;26(6):905-8
references.pmid: 12808312
references.citation: Biochemistry. 1997 Aug 5;36(31):9349-55
references.pmid: 9235977
references.citation: Am J Chin Med. 1996;24(1):11-7
references.pmid: 8739177
references.citation: Cell Biochem Funct. 2005 Sep-Oct;23(5):297-306
references.pmid: 15543642
references.citation: Biochim Biophys Acta. 1985 Apr 25;834(2):224-9
references.pmid: 3922420
references.citation: Br J Pharmacol. 2002 May;136(1):136-42
references.pmid: 11976278
references.citation: Food Chem Toxicol. 2009 Jan;47(1):163-70
references.pmid: 19022329
references.citation: Rheumatology (Oxford). 2010 Sep;49(9):1618-31
references.pmid: 20338884
references.citation: J Pharm Pharmacol. 2006 Jun;58(6):853-8
references.pmid: 16734987
references.citation: Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20523-8
references.pmid: 18077363
references.citation: J Immunol. 1997 Sep 15;159(6):2877-85
references.pmid: 9300711
references.citation: Lupus. 2002;11(4):240-8
references.pmid: 12043888
references.citation: Nat Rev Immunol. 2011 Jul 25;11(8):519-31
references.pmid: 21785456
references.citation: J Ethnopharmacol. 2004 Sep;94(1):59-65
references.pmid: 15261964
references.citation: Biochimie. 2010 Sep;92(9):1101-7
references.pmid: 20433892
references.citation: F1000 Med Rep. 2012;4:5
references.pmid: 22403586
references.citation: Free Radic Biol Med. 2005 Dec 1;39(11):1468-77
references.pmid: 16274882
references.citation: Bioorg Med Chem. 1998 Jun;6(6):833-9
references.pmid: 9681149
references.citation: Eur J Med Chem. 2008 May;43(5):996-1007
references.pmid: 17804122
references.citation: Am J Med. 2000 Jul;109(1):33-44
references.pmid: 10936476
references.citation: Bioorg Med Chem. 2007 Feb 1;15(3):1516-24
references.pmid: 17112729
references.citation: Curr Pharm Des. 2004;10(30):3797-811
references.pmid: 15579072
references.citation: Gen Pharmacol. 1996 Jun;27(4):713-22
references.pmid: 8853310
references.citation: Circulation. 2004 Mar 16;109(10):1196-205
references.pmid: 15023894
references.citation: J Cell Biochem. 2001;82(4):537-48
references.pmid: 11500931
references.citation: Biochem Biophys Res Commun. 1995 Jul 17;212(2):664-72
references.pmid: 7626081
references.citation: Curr Med Chem. 2009;16(32):4236-60
references.pmid: 19754420